Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?

Traumatic brain injury (TBI) constitutes a major health problem worldwide and is a leading cause of death and disability in individuals, contributing to devastating socioeconomic consequences. Despite numerous promising pharmacological strategies reported as neuroprotective in preclinical studies, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lerouet, Dominique, Marchand‐Leroux, Catherine, Besson, Valérie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290810/
https://www.ncbi.nlm.nih.gov/pubmed/33527472
http://dx.doi.org/10.1111/fcp.12656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290810/
https://www.ncbi.nlm.nih.gov/pubmed/33527472
http://dx.doi.org/10.1111/fcp.12656

Ejemplares similares